nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenbufen—PTGS1—malignant glioma	0.617	0.636	CbGaD
Fenbufen—PTGS2—malignant glioma	0.353	0.364	CbGaD
Fenbufen—PTGS2—S1P1 pathway—SPHK1—malignant glioma	0.000783	0.0375	CbGpPWpGaD
Fenbufen—Tolmetin—CXCL8—malignant glioma	0.000752	0.0755	CrCbGaD
Fenbufen—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—malignant glioma	0.000742	0.0355	CbGpPWpGaD
Fenbufen—Balsalazide—PPARG—malignant glioma	0.000719	0.0721	CrCbGaD
Fenbufen—PTGS2—C-MYB transcription factor network—YEATS4—malignant glioma	0.000658	0.0315	CbGpPWpGaD
Fenbufen—Ketorolac—PTGS1—malignant glioma	0.000596	0.0598	CrCbGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—PTGS1—malignant glioma	0.000581	0.0278	CbGpPWpGaD
Fenbufen—Bromfenac—PTGS1—malignant glioma	0.000571	0.0573	CrCbGaD
Fenbufen—Balsalazide—PTGS1—malignant glioma	0.000531	0.0533	CrCbGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—PTK2—malignant glioma	0.00051	0.0244	CbGpPWpGaD
Fenbufen—Tiaprofenic acid—PTGS1—malignant glioma	0.000486	0.0487	CrCbGaD
Fenbufen—PTGS2—Eicosanoid Synthesis—PTGS1—malignant glioma	0.000482	0.0231	CbGpPWpGaD
Fenbufen—Nepafenac—PTGS1—malignant glioma	0.000462	0.0464	CrCbGaD
Fenbufen—Bifonazole—CYP2B6—malignant glioma	0.00046	0.0461	CrCbGaD
Fenbufen—PTGS2—Spinal Cord Injury—ROS1—malignant glioma	0.000447	0.0214	CbGpPWpGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—PTK2—malignant glioma	0.000405	0.0194	CbGpPWpGaD
Fenbufen—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—malignant glioma	0.000403	0.0193	CbGpPWpGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—FN1—malignant glioma	0.000386	0.0185	CbGpPWpGaD
Fenbufen—Tolmetin—PTGS1—malignant glioma	0.000384	0.0385	CrCbGaD
Fenbufen—Salsalate—PTGS1—malignant glioma	0.000384	0.0385	CrCbGaD
Fenbufen—Oxaprozin—PTGS1—malignant glioma	0.000384	0.0385	CrCbGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000378	0.0181	CbGpPWpGaD
Fenbufen—Suprofen—PTGS1—malignant glioma	0.000368	0.0369	CrCbGaD
Fenbufen—Ketoprofen—CXCL8—malignant glioma	0.000367	0.0368	CrCbGaD
Fenbufen—PTGS1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00036	0.0172	CbGpPWpGaD
Fenbufen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—malignant glioma	0.000358	0.0172	CbGpPWpGaD
Fenbufen—Ketorolac—PTGS2—malignant glioma	0.000341	0.0342	CrCbGaD
Fenbufen—PTGS2—S1P1 pathway—PDGFB—malignant glioma	0.00034	0.0163	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—PIM1—malignant glioma	0.000337	0.0161	CbGpPWpGaD
Fenbufen—Bromfenac—PTGS2—malignant glioma	0.000326	0.0328	CrCbGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000325	0.0156	CbGpPWpGaD
Fenbufen—PTGS2—S1P1 pathway—KDR—malignant glioma	0.000319	0.0153	CbGpPWpGaD
Fenbufen—Fenoprofen—PTGS1—malignant glioma	0.000317	0.0318	CrCbGaD
Fenbufen—PTGS1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000312	0.0149	CbGpPWpGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—FN1—malignant glioma	0.000307	0.0147	CbGpPWpGaD
Fenbufen—Balsalazide—PTGS2—malignant glioma	0.000304	0.0305	CrCbGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—BCL2—malignant glioma	0.000295	0.0141	CbGpPWpGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—PTGS2—malignant glioma	0.000281	0.0134	CbGpPWpGaD
Fenbufen—Tiaprofenic acid—PTGS2—malignant glioma	0.000278	0.0279	CrCbGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000272	0.013	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—BCAN—malignant glioma	0.000271	0.013	CbGpPWpGaD
Fenbufen—PTGS2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000268	0.0128	CbGpPWpGaD
Fenbufen—Nepafenac—PTGS2—malignant glioma	0.000264	0.0265	CrCbGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000258	0.0124	CbGpPWpGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—BCL2—malignant glioma	0.000235	0.0112	CbGpPWpGaD
Fenbufen—PTGS1—Eicosanoid Synthesis—PTGS2—malignant glioma	0.000233	0.0111	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—MYB—malignant glioma	0.000225	0.0108	CbGpPWpGaD
Fenbufen—Salsalate—PTGS2—malignant glioma	0.000219	0.022	CrCbGaD
Fenbufen—Tolmetin—PTGS2—malignant glioma	0.000219	0.022	CrCbGaD
Fenbufen—Oxaprozin—PTGS2—malignant glioma	0.000219	0.022	CrCbGaD
Fenbufen—PTGS2—Spinal Cord Injury—GDNF—malignant glioma	0.000218	0.0105	CbGpPWpGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000216	0.0103	CbGpPWpGaD
Fenbufen—Suprofen—PTGS2—malignant glioma	0.00021	0.0211	CrCbGaD
Fenbufen—Flurbiprofen—PTGS1—malignant glioma	0.000207	0.0208	CrCbGaD
Fenbufen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—malignant glioma	0.000201	0.00964	CbGpPWpGaD
Fenbufen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—malignant glioma	0.000195	0.00932	CbGpPWpGaD
Fenbufen—PTGS1—Biological oxidations—CYP2B6—malignant glioma	0.000191	0.00916	CbGpPWpGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—TNF—malignant glioma	0.000189	0.00907	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—GFAP—malignant glioma	0.000188	0.00899	CbGpPWpGaD
Fenbufen—Ketoprofen—PTGS1—malignant glioma	0.000187	0.0188	CrCbGaD
Fenbufen—Fenoprofen—PTGS2—malignant glioma	0.000181	0.0182	CrCbGaD
Fenbufen—PTGS2—S1P1 pathway—VEGFA—malignant glioma	0.000175	0.0084	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—PTGS1—malignant glioma	0.000171	0.00817	CbGpPWpGaD
Fenbufen—PTGS1—Biological oxidations—CYP2C18—malignant glioma	0.000166	0.00794	CbGpPWpGaD
Fenbufen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malignant glioma	0.000166	0.00793	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—LGALS3—malignant glioma	0.000164	0.00786	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—SOD1—malignant glioma	0.000163	0.0078	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000157	0.0075	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—CAT—malignant glioma	0.000155	0.0074	CbGpPWpGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—TNF—malignant glioma	0.00015	0.0072	CbGpPWpGaD
Fenbufen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malignant glioma	0.000147	0.00705	CbGpPWpGaD
Fenbufen—PTGS1—Biological oxidations—GSTT1—malignant glioma	0.000134	0.00642	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—malignant glioma	0.000131	0.00625	CbGpPWpGaD
Fenbufen—PTGS1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000129	0.0062	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—SOD1—malignant glioma	0.000129	0.00619	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—CAT—malignant glioma	0.000123	0.00588	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—HES1—malignant glioma	0.000121	0.00579	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—NCOR1—malignant glioma	0.00012	0.00576	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000119	0.00568	CbGpPWpGaD
Fenbufen—Flurbiprofen—PTGS2—malignant glioma	0.000118	0.0119	CrCbGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000114	0.00544	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—F2—malignant glioma	0.000113	0.00543	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000113	0.00539	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malignant glioma	0.000107	0.00513	CbGpPWpGaD
Fenbufen—Ketoprofen—PTGS2—malignant glioma	0.000107	0.0107	CrCbGaD
Fenbufen—PTGS2—Spinal Cord Injury—GJA1—malignant glioma	0.000106	0.00506	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.0001	0.0048	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—malignant glioma	9.96e-05	0.00477	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—malignant glioma	9.54e-05	0.00457	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malignant glioma	9.52e-05	0.00456	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—RTEL1—malignant glioma	9.4e-05	0.0045	CbGpPWpGaD
Fenbufen—PTGS1—Biological oxidations—GSTP1—malignant glioma	9.3e-05	0.00445	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	9.18e-05	0.00439	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—F2—malignant glioma	9e-05	0.00431	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	8.65e-05	0.00414	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—IFNG—malignant glioma	8.59e-05	0.00411	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—PTGS2—malignant glioma	8.23e-05	0.00394	CbGpPWpGaD
Fenbufen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—malignant glioma	8.13e-05	0.00389	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	7.96e-05	0.00381	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	7.78e-05	0.00373	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—IL1B—malignant glioma	7.66e-05	0.00367	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—RTEL1—malignant glioma	7.46e-05	0.00357	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	7.41e-05	0.00355	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	7.35e-05	0.00352	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—CDKN2A—malignant glioma	7.25e-05	0.00347	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—BCL2—malignant glioma	7.14e-05	0.00342	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	7.14e-05	0.00342	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malignant glioma	6.94e-05	0.00332	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—IFNG—malignant glioma	6.82e-05	0.00326	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.72e-05	0.00322	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	6.63e-05	0.00318	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	6.58e-05	0.00315	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.5e-05	0.00311	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	6.08e-05	0.00291	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	5.97e-05	0.00286	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	5.56e-05	0.00266	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—COX8A—malignant glioma	5.4e-05	0.00259	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	5.39e-05	0.00258	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	5.34e-05	0.00256	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.33e-05	0.00255	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.16e-05	0.00247	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	5.01e-05	0.0024	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	4.92e-05	0.00235	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	4.81e-05	0.0023	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	4.8e-05	0.0023	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—IL2—malignant glioma	4.79e-05	0.00229	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	4.78e-05	0.00229	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	4.63e-05	0.00222	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—ASMT—malignant glioma	4.59e-05	0.0022	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	4.58e-05	0.00219	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	4.54e-05	0.00218	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	4.53e-05	0.00217	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.49e-05	0.00215	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	4.41e-05	0.00211	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—BCAN—malignant glioma	4.32e-05	0.00207	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—COX8A—malignant glioma	4.29e-05	0.00205	CbGpPWpGaD
Fenbufen—PTGS2—Disease—BCAN—malignant glioma	4.09e-05	0.00196	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	3.9e-05	0.00187	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.83e-05	0.00183	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—MYC—malignant glioma	3.75e-05	0.00179	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	3.7e-05	0.00177	CbGpPWpGaD
Fenbufen—PTGS2—Disease—DTX1—malignant glioma	3.7e-05	0.00177	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	3.66e-05	0.00175	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	3.65e-05	0.00175	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—ASMT—malignant glioma	3.64e-05	0.00174	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	3.63e-05	0.00174	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	3.6e-05	0.00172	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.56e-05	0.00171	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—TNF—malignant glioma	3.49e-05	0.00167	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—IDH2—malignant glioma	3.48e-05	0.00167	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—BCAN—malignant glioma	3.43e-05	0.00164	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.28e-05	0.00157	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—CYP2B6—malignant glioma	3.27e-05	0.00157	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.26e-05	0.00156	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—TP53—malignant glioma	3.08e-05	0.00147	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.07e-05	0.00147	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—IDH1—malignant glioma	2.99e-05	0.00143	CbGpPWpGaD
Fenbufen—PTGS2—Disease—HEY2—malignant glioma	2.9e-05	0.00139	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—SPHK1—malignant glioma	2.89e-05	0.00139	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—CYP2C18—malignant glioma	2.84e-05	0.00136	CbGpPWpGaD
Fenbufen—PTGS2—Disease—IDH1—malignant glioma	2.84e-05	0.00136	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.77e-05	0.00133	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—IDH2—malignant glioma	2.76e-05	0.00132	CbGpPWpGaD
Fenbufen—PTGS2—Disease—HEY1—malignant glioma	2.69e-05	0.00129	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.67e-05	0.00128	CbGpPWpGaD
Fenbufen—PTGS2—Disease—HIST1H3B—malignant glioma	2.61e-05	0.00125	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.6e-05	0.00125	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—CYP2B6—malignant glioma	2.6e-05	0.00124	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.55e-05	0.00122	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.49e-05	0.00119	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.44e-05	0.00117	CbGpPWpGaD
Fenbufen—PTGS2—Disease—JAG2—malignant glioma	2.38e-05	0.00114	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—IDH1—malignant glioma	2.38e-05	0.00114	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.37e-05	0.00114	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.35e-05	0.00113	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.35e-05	0.00113	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—SPHK1—malignant glioma	2.3e-05	0.0011	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—GSTT1—malignant glioma	2.29e-05	0.0011	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—CYP2C18—malignant glioma	2.25e-05	0.00108	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.16e-05	0.00104	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.14e-05	0.00103	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.12e-05	0.00102	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.09e-05	0.001	CbGpPWpGaD
Fenbufen—PTGS2—Disease—H3F3A—malignant glioma	2.02e-05	0.000966	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—BCHE—malignant glioma	2e-05	0.000957	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—SLC5A5—malignant glioma	1.97e-05	0.000945	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.93e-05	0.000926	CbGpPWpGaD
Fenbufen—PTGS2—Disease—JAG1—malignant glioma	1.9e-05	0.000911	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.87e-05	0.000894	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.87e-05	0.000894	CbGpPWpGaD
Fenbufen—PTGS2—Disease—FBXW7—malignant glioma	1.86e-05	0.000892	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.85e-05	0.000886	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—GSTT1—malignant glioma	1.82e-05	0.000872	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.77e-05	0.000846	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—PTGS1—malignant glioma	1.71e-05	0.000817	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.7e-05	0.000814	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.61e-05	0.000772	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—GSTP1—malignant glioma	1.59e-05	0.000761	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—BCHE—malignant glioma	1.59e-05	0.00076	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—SLC5A5—malignant glioma	1.57e-05	0.00075	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—CAT—malignant glioma	1.55e-05	0.000741	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.48e-05	0.00071	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—NCOR1—malignant glioma	1.46e-05	0.0007	CbGpPWpGaD
Fenbufen—PTGS2—Disease—CDKN2B—malignant glioma	1.46e-05	0.000699	CbGpPWpGaD
Fenbufen—PTGS2—Disease—HES1—malignant glioma	1.39e-05	0.000667	CbGpPWpGaD
Fenbufen—PTGS2—Disease—NCOR1—malignant glioma	1.38e-05	0.000663	CbGpPWpGaD
Fenbufen—PTGS2—Disease—PDGFRA—malignant glioma	1.33e-05	0.000635	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.28e-05	0.000613	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—GSTP1—malignant glioma	1.26e-05	0.000604	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—CAT—malignant glioma	1.23e-05	0.000588	CbGpPWpGaD
Fenbufen—PTGS2—Disease—TERT—malignant glioma	1.22e-05	0.000584	CbGpPWpGaD
Fenbufen—PTGS2—Disease—HLA-A—malignant glioma	1.22e-05	0.000584	CbGpPWpGaD
Fenbufen—PTGS2—Disease—PDGFB—malignant glioma	1.19e-05	0.00057	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—CAV1—malignant glioma	1.19e-05	0.00057	CbGpPWpGaD
Fenbufen—PTGS2—Disease—FGFR1—malignant glioma	1.19e-05	0.000567	CbGpPWpGaD
Fenbufen—PTGS2—Disease—HIF1A—malignant glioma	1.17e-05	0.000559	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—NCOR1—malignant glioma	1.16e-05	0.000555	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.14e-05	0.000545	CbGpPWpGaD
Fenbufen—PTGS2—Disease—CAV1—malignant glioma	1.13e-05	0.000541	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PIK3CG—malignant glioma	1.08e-05	0.000519	CbGpPWpGaD
Fenbufen—PTGS2—Disease—BAD—malignant glioma	1.06e-05	0.000508	CbGpPWpGaD
Fenbufen—PTGS2—Disease—NOTCH1—malignant glioma	1.05e-05	0.000504	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PPARG—malignant glioma	1.05e-05	0.000501	CbGpPWpGaD
Fenbufen—PTGS2—Disease—CD80—malignant glioma	1.03e-05	0.000493	CbGpPWpGaD
Fenbufen—PTGS2—Disease—APC—malignant glioma	1.03e-05	0.000492	CbGpPWpGaD
Fenbufen—PTGS2—Disease—EGF—malignant glioma	1.02e-05	0.000487	CbGpPWpGaD
Fenbufen—PTGS2—Disease—PTPN11—malignant glioma	1.01e-05	0.000484	CbGpPWpGaD
Fenbufen—PTGS2—Disease—BRAF—malignant glioma	9.67e-06	0.000463	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PIK3CD—malignant glioma	9.54e-06	0.000457	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—CAV1—malignant glioma	9.46e-06	0.000453	CbGpPWpGaD
Fenbufen—PTGS2—Disease—AKT2—malignant glioma	9.41e-06	0.000451	CbGpPWpGaD
Fenbufen—PTGS2—Disease—PIK3CD—malignant glioma	9.04e-06	0.000433	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.03e-06	0.000433	CbGpPWpGaD
Fenbufen—PTGS2—Disease—FGF2—malignant glioma	8.66e-06	0.000414	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—PIK3CG—malignant glioma	8.61e-06	0.000412	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PIK3CB—malignant glioma	8.31e-06	0.000398	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—PPARG—malignant glioma	8.31e-06	0.000398	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PTGS2—malignant glioma	8.24e-06	0.000394	CbGpPWpGaD
Fenbufen—PTGS2—Disease—MDM2—malignant glioma	8.1e-06	0.000388	CbGpPWpGaD
Fenbufen—PTGS2—Disease—RAF1—malignant glioma	8.07e-06	0.000386	CbGpPWpGaD
Fenbufen—PTGS2—Disease—ERBB2—malignant glioma	7.98e-06	0.000382	CbGpPWpGaD
Fenbufen—PTGS2—Disease—PIK3CB—malignant glioma	7.88e-06	0.000377	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—PIK3CD—malignant glioma	7.57e-06	0.000363	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PTEN—malignant glioma	7.18e-06	0.000344	CbGpPWpGaD
Fenbufen—PTGS2—Disease—PTEN—malignant glioma	6.81e-06	0.000326	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—PIK3CB—malignant glioma	6.6e-06	0.000316	CbGpPWpGaD
Fenbufen—PTGS2—Disease—STAT3—malignant glioma	6.09e-06	0.000292	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—PTEN—malignant glioma	5.7e-06	0.000273	CbGpPWpGaD
Fenbufen—PTGS2—Disease—MYC—malignant glioma	5.66e-06	0.000271	CbGpPWpGaD
Fenbufen—PTGS2—Disease—EGFR—malignant glioma	5.53e-06	0.000265	CbGpPWpGaD
Fenbufen—PTGS2—Disease—KRAS—malignant glioma	5.23e-06	0.00025	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PIK3CA—malignant glioma	5.07e-06	0.000243	CbGpPWpGaD
Fenbufen—PTGS2—Disease—PIK3CA—malignant glioma	4.8e-06	0.00023	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—AKT1—malignant glioma	4.14e-06	0.000198	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—PIK3CA—malignant glioma	4.02e-06	0.000193	CbGpPWpGaD
Fenbufen—PTGS2—Disease—AKT1—malignant glioma	3.92e-06	0.000188	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—AKT1—malignant glioma	3.29e-06	0.000157	CbGpPWpGaD
